Detalhe da pesquisa
1.
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
Clin Infect Dis
; 78(1): 144-148, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37606512
2.
Effectiveness of Bedaquiline Use beyond Six Months in Patients with Multidrug-Resistant Tuberculosis.
Am J Respir Crit Care Med
; 207(11): 1525-1532, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802336
3.
Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort.
Clin Infect Dis
; 75(6): 1006-1013, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35028659
4.
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs.
Clin Infect Dis
; 75(8): 1307-1314, 2022 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243494
5.
All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings.
Eur Respir J
; 59(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140298
6.
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
Am J Respir Crit Care Med
; 203(1): 111-119, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32706644
7.
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.
PLoS Med
; 14(1): e1002202, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28045934
8.
Rwanda 20 years on: investing in life.
Lancet
; 384(9940): 371-5, 2014 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-24703831
9.
Data for Program Management: An Accuracy Assessment of Data Collected in Household Registers by Community Health Workers in Southern Kayonza, Rwanda.
J Community Health
; 40(4): 625-32, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25502593
10.
Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death.
Clin Infect Dis
; 59(1): 9-15, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24729493
11.
Community-based accompaniment and psychosocial health outcomes in HIV-infected adults in Rwanda: a prospective study.
AIDS Behav
; 18(2): 368-80, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23443977
12.
Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis.
Nat Commun
; 15(1): 3927, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38724531
13.
Effectiveness of a bedaquiline, linezolid, clofazimine "core" for multidrug-resistant tuberculosis.
medRxiv
; 2024 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293100
14.
Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
Clin Infect Dis
; 56(9): 1319-26, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23249611
15.
Shared learning in an interconnected world: innovations to advance global health equity.
Global Health
; 9: 37, 2013 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24119388
16.
Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance.
Eur Respir J
; 50(1)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28729476
17.
Target regimen profiles for treatment of tuberculosis: a WHO document.
Eur Respir J
; 49(1)2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122858
18.
Reliability and construct validity of three health-related self-report scales in HIV-positive adults in rural Rwanda.
AIDS Care
; 24(12): 1576-83, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22428702
19.
Comprehensive treatment of extensively drug-resistant tuberculosis.
N Engl J Med
; 359(6): 563-74, 2008 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18687637
20.
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
Int J Infect Dis
; 113 Suppl 1: S91-S95, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823277